Geron (GERN) Liabilities and Shareholders Equity (2010 - 2026)

Geron's (GERN) quarterly Liabilities and Shareholders Equity came in at $534.1 million in Q1 2026, down 5.04% year-on-year from $562.4 million in Q1 2025, and down 6.38% quarter-over-quarter from $570.5 million in Q4 2025.

Geron (GERN) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Geron has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $534.1 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $534.1 million, down 5.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 8.62% YoY), and the FY2025 annual result was $570.5 million, down 3.91% from the prior year.
  • Liabilities and Shareholders Equity came in at $534.1 million for Q1 2026 at Geron, down from $570.5 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $593.8 million in Q4 2024 to a low of $190.6 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $445.0 million (2024), against an average of $427.5 million.
  • Across the five-year window, Liabilities and Shareholders Equity slipped 23.27% in 2022 and surged 114.13% in 2023, its largest moves.
  • Geron's Liabilities and Shareholders Equity stood at $190.6 million in 2022, then surged by 106.78% to $394.1 million in 2023, then jumped by 50.68% to $593.8 million in 2024, then fell by 3.91% to $570.5 million in 2025, then decreased by 6.38% to $534.1 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $534.1 million (Q1 2026), $570.5 million (Q4 2025), and $567.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 37.37 Mn
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - 14.93 Mn
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 1.73 Bn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - 33.89 Mn
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 23.64 Mn
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.71 Bn 91.71 Bn - 640.56 Mn
10 Geron 729,618.77 729,618.77 - 534.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 534.12 Mn
Dec 31, 2025 570.54 Mn
Sep 30, 2025 567.38 Mn
Jun 30, 2025 555.20 Mn
Mar 31, 2025 562.45 Mn
Dec 31, 2024 593.78 Mn
Sep 30, 2024 444.95 Mn
Jun 30, 2024 449.40 Mn
Mar 31, 2024 482.07 Mn
Dec 31, 2023 394.08 Mn
Sep 30, 2023 413.02 Mn
Jun 30, 2023 415.30 Mn
Mar 31, 2023 424.88 Mn
Dec 31, 2022 190.58 Mn
Sep 30, 2022 232.61 Mn
Jun 30, 2022 238.16 Mn
Mar 31, 2022 198.42 Mn
Dec 31, 2021 226.03 Mn
Sep 30, 2021 229.10 Mn
Jun 30, 2021 252.18 Mn